HuR and mRNA stability

Cellular and Molecular Life Sciences

Volumn 58, Issue 2, 2001, Pages 266-277

  Brennan, C M ^a   Steitz, J A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AU rich element; ELAV; Hu proteins; mRNA stability; Nuclear export; Stress

Indexed keywords

DROSOPHILA; GENE CONTROL; GENE EXPRESSION REGULATION; LIGAND BINDING; NONHUMAN; PROTEIN PROCESSING; REVIEW; RNA DEGRADATION; RNA STABILITY;

MAMMALIA;

EID: 0035099573     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000854     Document Type: Review

References (125)

1. Regulation of translation by specific protein/mRNA interactions
2. Messenger RNA degradation in eukaryotes
3. mRNA stability in mammalian cells
4. Regulation of mRNA turnover in eukaryotic cells
5. Degradation of mRNA in eukaryotes
6. Characterization of the XRN1 gene encoding a 5′ → 3′ exoribonuclease: Sequence data and analysis of disparate protein and mRNA levels of gene-disrupted yeast cells
7. The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif
8. Rat1p and Xrn1p are functionally interchangeable exoribonucleases that are restricted to and required in the nucleus and cytoplasm, respectively
9. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells
10. Translation initiation requires the PAB-dependent poly(A) ribonuclease in yeast
11. Isolation and characterization of an NTP-dependent 3′-exoribonuclease from mitochondria of Saccharomyces cerevisiae
12. The exosome: A proteasome for RNA?
13. The yeast Pan2 protein is required for poly(A)-binding protein-stimulated poly(A)-nuclease activity
14. PAN3 encodes a subunit of the Pab1p-dependent poly(A) nuclease in Saccharomyces cerevisiae
15. Poly(A) tail shortening by a mammalian poly(A)-specific 3′-exoribonuclease
16. The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes
17. Interaction between a poly(A)-specific ribonuclease and the 5′ cap influences mRNA deadenylation rates in vitro
18. Cap-dependent deadenylation of mRNA
19. The exosome: A conserved eukaryotic RNA processing complex containing multiple 3′ → 5′ exoribonucleases
20. The yeast exosome and human PM-Sc1 are related complexes of 3′ → 5′ exonucleases
21. Stabilization of interleukin-2 mRNA by the c-jun NH2-terminal kinase pathway
22. Translation and a 42-nucleotide segment within the coding region of the mRNA encoded by the MAT alpha 1 gene are involved in promoting rapid mRNA decay in yeast
23. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways
24. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors
25. Making sense of nonsense in yeast
26. When cells stop making sense: Effects of nonsense codons on RNA metabolism in vertebrate cells
27. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide and oxidative stress
28. Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells
29. Detection and characterization of a 3′ untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability
30. Translational control of developmental decisions
31. Translational control of developmental decisions
32. AU-rich elements: Characterization and importance in mRNA degradation
33. c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene
34. Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene
35. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences
36. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
37. Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences
38. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A)
39. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
40. A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy
41. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice
42. Transcriptional activation by tetracyclines in mammalian cells
43. Poly(A) shortening and degradation of the 3′ A + U-rich sequences of human c-myc mRNA in a cell-free system
44. Characterization of c-myc 3′ to 5′ mRNA decay activities in an in vitro system
45. Evidence for a 3′-5′ decay pathway for c-myc mRNA in mammalian cells
46. An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro
47. Posttranscriptional regulation of vascular endothelial growth factor by hypoxia
48. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
49. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system
50. p53-dependent elevation of p21Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system
51. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway
52. Interleukin-3 mRNA stabilization by a trans-acting mechanism in autocrine tumors lacking interleukin-3 gene rearrangements
53. c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells
54. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes
55. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism
56. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA
57. A redox switch and phosphorylation are involved in the post-translational upregulation of the adenosine-uridine binding factor by phorbol ester and ionophore
58. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA
59. AU RNA-binding factors differ in their binding specificities and affinities
60. He1-N1: An autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factor mRNAs
61. Purification, characterization and cDNA cloning of an AU-rich element RNA-binding protein, AUF1
62. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences
63. AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity
64. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold)
65. Isolation and characterization of a novel, low abundance hnRNP protein: A0
66. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein
67. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay
68. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin
69. Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA
70. A specific isoform of hnRNP D interacts with DNA in the LR1 heterodimer: Canonical RNA binding motifs in a sequence-specific duplex DNA binding protein
71. RNA binding specificity of hnRNP proteins: A subset bind to the 3′ end of introns
72. The human HNRPD locus maps to 4q21 and encodes a highly conserved protein
73. Transcriptional pulsing approaches for analysis of mRNA turnover in mammalian cells
74. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway
75. A conserved family of elav-like genes in vertebrates
76. Mutant alleles at the locus elav in Drosophila melanogaster lead to nervous system defects. A developmental-genetic analysis
77. AU-rich elements target small nuclear RNAs as well as mRNAs for rapid degradation
78. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs
79. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein
80. HuR regulates p21 mRNA stabilization by UV light
81. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation
82. The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA
83. HNS, a nuclear-cytoplasmic shuttling sequence in HuR
84. HuR binding to cytoplasmic mRNA is perturbed by heat shock
85. Protein ligands to HuR modulate its interaction with target mRNAs in vivo
86. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
87. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: Characterization of the set gene
88. Template activating factor I, a novel host factor required to stimulate the adenovirus core DNA replication
89. Identification and preliminary characterization of two related proliferation-associated nuclear phosphoproteins
90. Expression analysis and chromosomal mapping of a novel human gene, APRIL, encoding an acidic protein rich in leucines
91. Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A
92. Functional domains of template-activating factor-I as a protein phosphatase 2A inhibitor
93. Regulation of protein kinase cascades by protein phosphatase 2A
94. The interconversion of protein phosphatase 2A between PP2A1 and PP2A0 during retinoic acid-induced granulocytic differentiation and a modification on the catalytic subunit in S phase of HL-60 cells
95. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors
96. 12-O-Tetradecanoylphorbol-13-acetate-induced dephosphorylation of protein kinase C alpha correlates with the presence of a membrane-associated protein phosphatase 2A heterotrimer
97. Protein phosphatase 2A inactivates the mitogen-stimulated S6 kinase from Swiss mouse 3T3 cells
98. A signaling complex of Ca2 +-calmodulin-dependent protein kinase IV and protein phosphatase 2A
99. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase
100. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases
101. Leptomycins A and B, new antifungal antibiotics. I. Taxonomy of the producing strain and their fermentation, purification and characterization
102. Leptomycins A and B, new antifungal antibiotics. II. Structure elucidation
103. Antitumor activity of leptomycin B
104. The neuron-enriched splicing pattern of Drosophila erect wing is dependent on the presence of ELAV protein
105. Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems
106. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal
107. Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation and posttranscriptional gene expression
108. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease
109. NMR studies on functional structures of the AU-rich element-binding domains of Hu antigen C
110. Ectopic expression of He1-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes
111. Cytoplasmic localization is required for the mammalian ELAV-like protein HuD to induce neuronal differentiation
112. Sequential expression and role of Hu RNA-binding proteins during neurogenesis
113. ELAV tumor antigen, He1-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells
114. Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells
115. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets
116. Inhibitory activity of the human papillomavirus type 1 AU-rich element correlates inversely with the levels of the elav-like HuR protein in the cell cytoplasm
117. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules
118. Purification and characterization of β-adrenergic receptor mRNA-binding proteins
119. The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels
120. The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3′ untranslated region correlates with its affinity for the elav-like HuR protein
121. Viral small nuclear ribonucleoproteins bind a protein implicated in messenger RNA destabilization
122. Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3′-untranslated region of the neurofibromin messenger RNA
123. An AU-rich sequence in the 3′-UTR of plasmminogen activator inhibitor type 3 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR
124. The Elav-like proteins bind to a conserved regulatory element in the 3′-untranslated region of GAP-43 mRNA